1. Home
  2. AGCO vs MIRM Comparison

AGCO vs MIRM Comparison

Compare AGCO & MIRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AGCO Corporation

AGCO

AGCO Corporation

HOLD

Current Price

$120.97

Market Cap

8.8B

Sector

Industrials

ML Signal

HOLD

Logo Mirum Pharmaceuticals Inc.

MIRM

Mirum Pharmaceuticals Inc.

HOLD

Current Price

$113.17

Market Cap

7.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AGCO
MIRM
Founded
1990
2018
Country
United States
United States
Employees
22000
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.8B
7.2B
IPO Year
1994
2019

Fundamental Metrics

Financial Performance
Metric
AGCO
MIRM
Price
$120.97
$113.17
Analyst Decision
Hold
Strong Buy
Analyst Count
11
13
Target Price
$119.09
$119.85
AVG Volume (30 Days)
625.6K
734.0K
Earning Date
05-05-2026
05-06-2026
Dividend Yield
1.05%
N/A
EPS Growth
271.35
74.59
EPS
0.76
N/A
Revenue
$10,082,000,000.00
$19,138,000.00
Revenue This Year
$6.52
$26.22
Revenue Next Year
$5.56
$22.04
P/E Ratio
$154.30
N/A
Revenue Growth
N/A
N/A
52 Week Low
$99.21
$50.25
52 Week High
$143.78
$130.00

Technical Indicators

Market Signals
Indicator
AGCO
MIRM
Relative Strength Index (RSI) 61.55 45.58
Support Level $109.31 $87.93
Resistance Level $121.00 $114.99
Average True Range (ATR) 3.42 5.09
MACD 0.46 -1.87
Stochastic Oscillator 98.37 13.88

Price Performance

Historical Comparison
AGCO
MIRM

About AGCO AGCO Corporation

Agco is a global manufacturer of agricultural equipment. Its main machine brands are Fendt, Massey Ferguson, and Valtra; its initiatives in precision agriculture have been organized under the PTx umbrella following a series of acquisitions. While a global business, Agco's sales skew heavily toward Europe/Middle East, representing 50%-60% of sales and even more of operating profits. The company is trying to increase its exposure to the larger North and South American markets. Its products are available through a global dealer network, which includes over 3,000 dealers and distribution locations and reaches into over 140 countries. Additionally, Agco offers retail and wholesale financing to customers through its partnership with Rabobank of the Netherlands, having exited their JV in 2026.

About MIRM Mirum Pharmaceuticals Inc.

Mirum Pharmaceuticals Inc. is a biopharmaceutical company focused on developing and commercializing therapies for rare and orphan diseases. Its main product, Livmarli (maralixibat), is an orally administered IBAT inhibitor approved to treat cholestatic pruritus in patients with Alagille syndrome. The company is also developing treatments such as maralixibat for PFIC and ALGS, and volixibat for adult cholestatic liver diseases. Mirum currently has three approved medicines: Livmarli, Cholbam, and Ctexli.

Share on Social Networks: